Mobile health application for liver cirrhosis rehabilitation
The Effect of the Use of ReLiver-N App Developed for Patients With Liver Cirrhosis on Hepatic Rehabilitation: A Randomized Controlled Single-Blind Study
This study is testing a new mobile app designed to help people with liver cirrhosis better manage their health and improve their recovery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 52 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Akdeniz University Academic / other |
| Locations | 1 site (Antalya) |
| Trial ID | NCT06995196 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to develop and evaluate a nurse-led mobile health application called ReLiver-N App, designed to enhance hepatic rehabilitation for patients with liver cirrhosis. The app will provide comprehensive health education, patient activation practices, and a clinical decision system to facilitate active patient participation in their care. The study will assess the effectiveness of the app in improving patient outcomes through a methodological phase followed by a randomized controlled experimental phase. Feedback will be provided to patients based on their health evaluations to ensure continuous support and improvement.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older diagnosed with liver cirrhosis classified as Child-Pugh A or B.
Not a fit: Patients with Child-Pugh C category liver cirrhosis, those who are pregnant, have undergone liver transplantation, or have certain psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the health outcomes and quality of life for patients with liver cirrhosis.
How similar studies have performed: While the specific approach of using a mobile health application for hepatic rehabilitation is innovative, similar studies have shown promise in utilizing technology for chronic disease management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Diagnosed with liver cirrhosis Had Child-Pugh A and B categories 18 years of age or older No barriers to verbal or written communication Having internet at home and a smartphone Patients who consented to participate in the study. Exclusion Criteria: Had Child-Pugh C category Had pregnant Liver transplanted Diagnosed with hepatocellular carcinoma Having dementia Having been diagnosed with a psychiatric disease
Where this trial is running
Antalya
- Akdeniz University — Antalya, Turkey (Recruiting)
Study contacts
- Study coordinator: Ferya Celik, PhD
- Email: feryacelik@gmail.com
- Phone: +90 242 226 13 58
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.